Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in ...
Researchers discovered semaglutide—the active ingredient in Ozempic and Wegovy—may reduce the risk of death and lower the chance of developing cardiovascular conditions like stroke and heart ...
Tirzepatide reduced the risk of heart failure outcomes – heart failure ... However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of drug ...
Drug manufacturer Eli Lilly announced the results from a three-year study that found its drug tirzepatide slashed the risk of developing type 2 diabetes by 94% in adults with prediabetes who also ...
A three-year study of tirzepatide – a medication approved ... such as high blood pressure or heart disease. Like similar drugs, it’s used as a shot patients give themselves once a week and ...
Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, reduced the risk of developing type 2 diabetes by 94% in adults with ...
Pregnancy-Related Heart Failure Is Under-Detected; AI-Enabled Stethoscope Helped Doctors Diagnose Twice as Many Cases Sep. 3, 2024 — Heart failure during pregnancy is a dangerous and often under ...
This can lead to long-term complications like heart failure and arrhythmias that will need to be managed as well. Heart attacks are serious, but the good news is that they’re very preventable.
Federal Reserve interest rate cuts can have a big effect on investor portfolios. For example, some sectors and industries historically outperform in lower-rate environments. If Fed rate cuts occur ...
Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. Tirzepatide is less expensive and may be more effective. However, the drug is still new, and more research is ...
On today's episode of Asking for a Trend, Host Josh Lipton breaks down some of the top stories and trends from the trading day. Investors are all but certain the Federal Reserve will cut interest ...
